MEXICO FUND (NY:MXF)
22.05
+0.03 (0.14%)
| MEXICO FUND (NY:MXF) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $22.02 | 52 Week High | $22.60 | ||
| Open | $22.05 | 52 Week Low | $10.25 | ||
| Day High | $22.05 | P/E | N/A | ||
| Day Low | $21.85 | EPS | $0.00 | ||
| Volume | 21,473 | ||||
| More MXF Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| ASR | 1 | GSK | 1 |
| SVA | 1 | CEA | 1 |
| LMNX | 1 | DAL | 1 |
| PURE | 1 | ASR | 1 |
| GSK | 1 | SVA | 1 |
| CERS | 1 | LUV | 1 |
View All Press ReleasesCompany Press Releases on MXF
- The Mexico Fund, Inc. Publishes Schedule of In-Kind Proceeds Distributed in Connection With Tender Offer
- The Mexico Fund, Inc. Pays Distribution
- Webcast Alert: Closed-End Fund Conference Series
- Mexico Fund Announces Final Results of In-Kind Tender Offer
- Mexico Fund Announces Preliminary Results of In-Kind Tender Offer
StreetInsider Reports on MXF by Category
View All BlogsBlogs on MXF
- Marijuana, LSD, Cocaine Now Legal in Mexico. Will the Economy Benefit?
- Index ETFs Have the Edge Over Actively Managed CEFs
- Fundamental Valuation in Emerging Markets
- Emerging Markets With Low Valuations
- Trading Closed-End Funds - An Update
View All FilingsSEC Filings on MXF
- Form 4 CLARIOND EUGENIO For: Nov 03
- Form 4 CLARIOND EUGENIO For: Oct 28
- Form 4 MEXICO FUND INC For: Oct 26 Filed by: CLARIOND EUGENIO
Comments on recent MXF articles
Comments on MXF
No comments are currently available.
on Jun 14, 2009
at 05:38 PM ASFX has a swine flu product ASFX.pk sells the thermofocus at walgreens and babies-r-us. It's a no-touch thermometer and orders are going through the roof. Buy one for yourself so you can take temperatures with out getting the swine flu! http://finance.yahoo.com/news/Safety-Product-Company-Sees-prnews-15504232.html?.v=1 This thermometer (Thermofocus) was used heavily in ASIA during SARS
Article: Swine Flu Stock Rundown
on Apr 27, 2009
at 10:51 PM 3M's New Flu Test I am surprised that this article didn't mention Response Biomedical (TSX: RBM), which makes the rapid flu test marketed by 3M as the 3M Rapid Detection Flu A + B Test. It was just launched in the fall and is a more accurate and sophisticated test than the other point of care tests on the market, like Quidel. By the way, RBM is also partnered with Roche (maker of Tamiflu) in an agreement to supply all of Roche's point of care cardiology tests and Cardiac Readers, which just launched in March of April.
Article: Swine Flu Stock Rundown